MedTrace Logo

miRNA Biomarkers in Multiple Sclerosis

NCT04772495 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2021-02-26

No results posted yet for this study

Summary

Multiple Sclerosis (MS) characterized by demyelination and axonal degeneration is a chronic inflammatory disease of the central nervous system (CNS). Recent studies have shown that dysregulated miRNAs alter immune responses, so they may have roles basis on various genetic diseases such as MS and may be potential targets for biomarkers and new therapeutic approaches. In this study, we evaluated the dysregulation of miRNA expression levels at MS and MS stages. We also discussed the potential of these miRNAs to be biomarkers and/or therapeutic targets in MS.

Conditions

Interventions

GENETIC

miRNA

miRNA effect on Multiple sclerosis pathology

Sponsors & Collaborators

  • University of Gaziantep

    lead OTHER

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-05-31
Completion
2017-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04772495 on ClinicalTrials.gov